Five U-M faculty members elected to National Academy of Medicine

October 20, 2020  //  FOUND IN: Our Employees

Five U-M professors have been elected to the highest honorary society in the United States for researchers in medicine and health.

They study everything from the brain to health care policy and cancer care, and all have demonstrated decades of expertise and achievement.

On Monday, F. DuBois Bowman, Justin B. Dimick, Christopher R. Friese, Karin M. Muraszko and Henry L. Paulson join a select group of fewer than 60 current and emeritus U-M faculty, and living former faculty, in the National Academy of Medicine.

F. DuBois Bowman, Ph.D.

A renowned expert in the statistical analysis of brain imaging data, F. DuBois Bowman is dean of the U-M’s School of Public Health. Bowman’s work mines massive data sets and has important implications for mental and neurological disorders such as Parkinson’s disease, Alzheimer’s disease, depression, schizophrenia and substance addiction. His research has helped reveal brain patterns that reflect disruption from psychiatric diseases, detect biomarkers for neurological diseases, and determine more individualized therapeutic treatments. Additionally, his work seeks to determine threats to brain health from environmental exposures.

As a principal investigator, Bowman has received seven NIH grants, has been a co-investigator on several federally sponsored grants, and has been an integral collaborator on an international research project led by the Michael J. Fox Foundation. Bowman has also served on advisory boards for NIH programs that target underrepresented minority undergraduate students at historically black colleges and universities and has led NIH diversity pipeline training programs.

Justin B. Dimick, M.D., M.P.H.

Justin B. Dimick, the Frederick A. Coller Distinguished Professor and Department of Surgery Chair at U-M, has been elected to the NAM for his leadership in elevating the science of health care policy evaluation, quality measurement and comparative effectiveness research within surgical populations.

With R01 funding from the Agency for Healthcare Research and Quality (AHRQ) and National Institutes of Health (NIH), his research focuses on quality measurement, policy evaluation and large-scale, innovative quality improvement interventions. Dimick’s research has revealed widespread variation in how surgery patients fare after their operations, and the importance of surgeon, hospital and policy factors that impact that variation. His work won him the medical school’s Clinical and Health Services Research Award, and election to the American Society of Clinical Investigation, the American Surgical Association and the Society of Clinical Surgery.

Christopher R. Friese, Ph.D., R.N., AOCN®, FAAN

Christopher Friese is the Elizabeth Tone Hosmer Professor at the U-M School of Nursing, where he focuses on measuring and improving the quality of cancer care delivery. He directs the Center for Improving Patient and Population Health. In 2020, he was appointed as the Associate Director for Cancer Control and Population Sciences at the Rogel Cancer Center.

He is also a faculty investigator at the university’s Institute for Healthcare Policy and Innovation. He has practiced as a staff nurse at leading cancer centers, including the University of Pennsylvania, Johns Hopkins Hospital and the Rogel Cancer Center. Friese is a national expert in the analyses of claims data to study care quality and has executed large surveys of ambulatory oncology nurses. The author of over 90 publications, his research findings were among the first to establish a significant relationship between favorable nurse practice environments and lower surgical mortality.

Karin M. Muraszko, M.D., FAANS

Karin M. Muraszko leads Michigan Medicine’s Department of Neurosurgery, a position she has held since 2005 when she became the first woman in the country to chair an academic neurosurgery department.

The NAM elected Muraszko to the Class of 2020 for her expertise on the treatment of individuals with brain tumors and congenital neurologic anomalies. She pioneered localized injection therapy with immunotoxin for leptomeningeal disease, presented the first prospective analysis of cerebellar mutism after posterior fossa surgery, and characterized development of syrinx spinal cord cavities with Chiari 1 malformation.

Henry L. Paulson, M.D., Ph.D.

Henry L. Paulson is the Lucile Groff Professor of Neurology for Alzheimer’s Disease and Related Disorders in the Michigan Medicine Department of Neurology. Paulson currently directs the Michigan Alzheimer’s Disease Center and co-directs the U-M Protein Folding Diseases Initiative.

Paulson’s research and clinical interests concern the causes and treatment of age-related neurodegenerative diseases, with an emphasis on polyglutamine diseases, Alzheimer’s disease and frontotemporal dementia. In 1997, his lab described abnormal protein aggregates in the polyglutamine diseases, which now are recognized as a pathological hallmark in this important class of inherited diseases.

Using test tube, cell-based and animal models, he has contributed to advances in the understanding of various neurodegenerative diseases. His lab also has helped pioneer the use of gene silencing methods as potential therapy for the many neurological disorders caused by “toxic” mutant genes.